Source: International Congress 2017 – Markers of COPD progression
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Antus (Budapest, Hungary). Assessment of serum uric acid in COPD exacerbations. 1086

Member's Comments

No comment yet.

Related content which might interest you: Serum uric acid levels among patients with COPD exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 33s Year: 2006 Serum uric acid and uric acid/creatinine ratio in exacerbations of COPD Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Serum uric acid as a predictor of mortality and future exacerbations of COPD Source: Eur Respir J 2014; 43: 43-53 Year: 2004 Serum uric acid levels among COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 435s Year: 2003 Does serum uric acid levels predict in-hospital mortality in severe COPD exacerbations? Source: International Congress 2015 – COPD: interesting notes Year: 2015 Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease? Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Serum ascorbic acid concentration in patients with acute pneumonia and in COPD patients with and without respiratory failure Source: Eur Respir J 2004; 24: Suppl. 48, 92s Year: 2004 Urinary uric acid excretion and overnight change in the urinary uric acid: creatinin ratio as a marker of tissue hypoxia in patients with COPD and OSA Source: Eur Respir J 2006; 28: Suppl. 50, 408s Year: 2006 Blood plasma levels of ascorbic acid in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 674s Year: 2006 Serum lysophosphatidic acid levels and exacerbation frequency in chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung Year: 2020 Serum ascorbid acid concentration in COPD patients with partial and with complete respiratory failure Source: Eur Respir J 2001; 18: Suppl. 33, 209s Year: 2001 Serum levels of hyaluronic acid are associated with COPD severity and predict survival Source: Eur Respir J, 53 (3) 1801183; 10.1183/13993003.01183-2018 Year: 2019 Serum magnesium levels in acute exacerbation of COPD Source: Annual Congress 2007 - Exacerbations of COPD Year: 2007 Association of serum uric acid levels and outcomes of patients with Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Hyaluronic acid in COPD exacerbations of different etiology Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Assessment of malondialdehyde in the airways during treatment of COPD exacerbations Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 The Relationship between serum uric acid and airflow limitation in the general Japanese population Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 Relationship of circulating hyaluronic acid levels to disease control in asthma and asthmatic pregnancy Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Association of serum bilirubin and clinical outcomes in COPD Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes Year: 2019